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Abstract
Background: The effect of adding clonidine to local anesthetics for nerve or plexus blocks remains unclear. Most
of the studies in adults have demonstrated the positive effects of clonidine on intra- and postoperative analgesia
when used as an adjunctive agent or in some cases as a single to regional techniques. In the pediatric population,
there are only few trials involving clonidine as an adjunct to regional anesthesia, and the analgesic benefits are not
definite in this group of patients. The evidence concerning perineural administration of clonidine is so far
inconclusive in children, as different types and volume of local anesthetic agents have been used in these studies.
Moreover, the efficacy of regional anesthesia is largely affected by the operator’s technique, accuracy and severity
of operation.
Methods: The use of clonidine alone or combined with 0.2% ropivacaine for effective analgesia after mild to
moderate painful foot surgery was assessed in 66 children, after combined sciatic lateral popliteal block (SLPB) plus
femoral block. The patients were randomly assigned into three groups to receive placebo, clonidine, and clonidine
plus ropivacaine. Time to first analgesic request in the groups was analyzed by using Kaplan-Meier and the log-
rank test (mean time, median time, 95% CI).
Results: In our study, clonidine administered alone in the SLPB seems promising, maintaining intraoperatively the
hemodynamic parameters SAP, DAP, HR to the lower normal values so that no patient needed nalbuphine under
0.6 MAC sevoflurane anesthesia, and postoperatively without analgesic request for a median time of 6 hours. In
addition, clonidine administered as adjuvant enhances ropivacaine’s analgesic effect for the first postoperative day
in the majority of children (p = 0.001). Clonidine and clonidine plus ropivacaine groups also didn’t demonstrate
PONV, motor blockade, and moreover, the parents of children expressed their satisfaction with the excellent
perioperative management of their children, with satisfaction score 9.74 ± 0.45 and 9.73 ± 0.70 respectively. On the
contrary all the patients in the control group required rescue nalbuphine in the recovery room, and
postoperatively, along with high incidence of PONV, and the parents of children reported a low satisfaction score
(7.50 ± 0.70).
Conclusions: Clonidine appears promising more as an adjuvant in 0.2% ropivacaine and less than alone in the
SLPB plus femoral block in children undergoing mild to moderate painful foot surgery, with no side effects.
Trial registration: ClinicalTrials.gov, ISRCTN90832436, (ref: CCT-NAPN-20886).
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The clinical importance of clonidine in peripheral blocks
of children and adults for effective intra - and post-
operative analgesia is controversial and subjected to an
ongoing debate.
In adults, the majority of the studies (reviews and
meta-analyses randomized trials) have demonstrated the
positive effects of clonidine on intra - and postoperative
pain relief, when used as an adjunctive agent to periph-
eral nerve blocks [1-5].
Moreover, clonidine alone may have a potential role to
produce analgesia when used for regional techniques in
adults [6-8].
In the pediatric population, there are only few trials
involving clonidine as an adjunct to peripheral blocks,
and the analgesic benefits are not definite in this group
of patients. The clinical benefits of clonidine in moder-
ate and severe painful surgeries remain questionable
[9,10] or potentially with limited analgesia [11,12]. How-
ever, in a pediatric pilot study, a trend has been demon-
strated for better postoperative analgesia following
peripheral administration of clonidine compared with
central use [13]. Moreover, there are controversies if
caudal or systemic administration of clonidine can also
enhance regional block in children [14-16].
Our hypothesis was that clonidine alone or combined
with 0.2% ropivacaine could produce a long lasting
block after foot and ankle surgery, adequate for the first
postoperative day.
The aim of the present randomized, prospective, con-
trolled study was to determine whether the use of cloni-
dine alone or combined with 0.2% ropivacaine, as single
shot, in the sciatic lateral popliteal block (SLPB) plus
femoral block, could provide adequate intra-and post-
operative analgesia in children undergoing mild to mod-
erate painful foot and ankle surgery.
Methods
Patients, Randomization and Blindness
Between January 2009 to May 2010, children, ASA phy-
sical status I and II, aged 5-14 years were scheduled for
elective mild to moderate painful foot and ankle surgery.
According to the power analysis, 66 children should be
studied. During the study, eleven children with neurolo-
gic or neuromuscular disease, problems in communica-
tion, skin infection at the site of needle insertion, or
children’s parents refusal were excluded. We used a
computer generated table program to produce random
numbers. We made a choice of twenty one (n = 21) ran-
dom numbers from 1 till 66 in order to be in the con-
trol group, twenty three (n = 23) random numbers
remained from the first choice to be in the clonidine
group, and the rest twenty two (n = 22) numbers to be
in the clonidine plus 0.2% ropivacaine group. The inves-
tigators were blind to the group assignment. The pla-
cebo or the treatment solutions were prepared by the
pharmacy and supplied to the Department of Anesthesia
in syringes labeled with predetermined code for each
solution. There were two syringes for the SLPB and the
femoral block respectively. In the SLPB, the syringes
contained a) for the control group isotonic saline 10 ml
plus 0.25 ml/kg and saline 0.13 ml/kg, b) for the cloni-
dine group isotonic saline 10 ml plus 0.25 ml/kg, and
clonidine 2 μg/kg (0.13 ml/kg) respectively. c) finally in
the clonidine plus 0.2% ropivacaine group the syringes
contained 0.2% ropivacaine 10 ml plus 0.25 ml/kg (max-
imum 25 ml) and clonidine 2 μg/kg (0.13 ml/kg) respec-
tively. Similarly in the femoral block the syringes
contained a) for the control group isotonic saline: 0.4
ml/kg and 0.065 ml/kg respectively, b) for the clonidine
group isotonic saline 0.4 ml/kg and clonidine 1 μg/kg
(0.065 ml/kg) respectively, and c) for clonidine plus
0.2% ropivacaine group 0.2% ropivacaine 0.4 ml/kg and
clonidine μg/kg (0.065 ml/kg) respectively. The maxi-
mum dose of 0.2% ropivacaine was decided to be 3.5
mg/kg and for clonidine 3 μg/kg.
The children were enrolled in the study after approval
o fT h eS c i e n t i f i cE t h i c sC o m m i t t e e( G e n e r a lC h i l d r e n ’s
Hospital, Penteli, Athens). Preoperatively, we explained
to parents our intervention treatment. After understand-
ing and accepting the alternative treatments by rando-
mization, without coercion or manipulation, written
informed consent was obtained in the card anesthesia.
Anesthetic technique
No premedication was used. General anesthesia was
induced with sevoflurane 8% and maintained with sevo-
f l u r a n ea d j u s t e du pt o2 . 6 %( 1 . 3M A C )t oc o n t r o lt h e
hemodynamic responses in an oxygen air mixture in a 1/
2 ratio and followed by a combined SLPB plus femoral
block. Regional blocks were performed by the two
anesthesiologists and operations by two surgeons. After
the performance of nerve blocks, all patients received cis-
atracurium (0.1 mg/kg) and trachea was intubated. Nal-
buphine infusion 0.03 mg/kg/h was administered in all
patients over 15 min period after the performance of
nerve blocks. Additional nalbuphine (0.03-0.09 mg/kg/h)
was administered during surgery in the case of persistent
tachycardia and hypertension (defined as values 15%
more than baseline) in patients that did not respond to
i n c r e a s e di n s p i r e ds e v o f l u r a ne concentration. Heart rate
(HR), arterial systolic and diastolic pressure (SAP, DAP),
SPO2, were recorded preoperatively (baseline, time 0) and
intraoperatively, plus PetCO2, every 15 min until the end
of the operation. The total amount of nalbuphine was
also recorded at the end of the operation.
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In the anesthetized children in the supine position, the
SLPB [17-19] was performed, using 100 mm or 50
mm, 21 gauge insulated stimulated needle (Stimuplex
B, Braun Medical, Bethlehem, PA). The sciatic nerve
was localized by means of a nerve stimulator, with a
stimulating current ranged between 0.45-0.55 (< 0.6)
mA, eliciting strong inversion (deep peronial DP,
branch of the CPN plus TN) or plantar flexion (tibial
nerve TN) or dorsiflexion (common peronial nerve
CPN) of the foot. An additional femoral block [18]
became necessary for the use of tourniquet in the area
around the thigh. After the performance of blocks a
pneumatic tourniquet at 150 mmHg was applied to the
mid-thigh.
Postoperative analgesic protocol
Postoperative analgesia was assessed by by means of a
color analogue scale (CAS) [20]. Patients with mild or
moderate postoperative pain (CAS score > 30 to 45 mm
and 46 to 55 mm respectively) received nalbuphine 0.2
mg/kg and 0.3 mg/kg respectively.
Data
I nt h er e c o v e r yr o o m ,a n dt h eo r t h o p e d i cw a r dt h ef o l -
lowing data were collected by the anesthesiologists: (a)
time to first analgesic request of nalbuphine after the
surgery; (b) pain CAS score at rest, was assessed in the
r e c o v e r yr o o m( t i m e : 0 ) ,2 ,4 ,6 ,8 ,1 8 ,2 4h o u r sp o s t -
operatively, and the tourniquet pain (time:0). CAS ran-
ging from 0 to 100 mm, with 100 mm being the worst
pain imaginable; (c) total number of rescue nalbuphine
doses and the total amount of nalbuphine for the 24
hours observational period; (d) duration of sensory
b l o c kb yt e s t i n gs e n s a t i o n( p i np r i c k )i nt h ed i s t r i b u -
tion area of the sciatic nerve postoperatively. The
degree of sensory block was classified as follows: 0:
normal sensation, 1: blunted sensation (analgesia), 2:
absence of sensation (anesthesia); (e) duration of
motor block postoperatively. Motor block was assessed
with voluntary plantar flex (TN), or dorsiflex (CPN)
patient’s foot and was classified as follows: 0: normal
movement, 1: decreased movement (incomplete motor
block), and 2: no movement (complete motor block);
(f) restless as dichotomous (yes or no); (g) incidence of
nausea and/or vomiting; (h) sedation level using a four
- point scale (0: awake, 1: drowsy, 2: asleep but easily
arousable with verbal command, 3: asleep but not
easily arousable, only by tactile stimulation), was
checked; (i) side effects from the SLPB; (k) satisfaction
score was assessed by the parents of children the sec-
ond postoperative day , using a numerical scale ranged
from 0 to 10.
Statistical analysis
Ordinal data were presented as mean ± SD or ± SE as
indicated. The one way ANOVA and the test Bonferroni
were used to compare the absolute values of variables
between the groups and pair wise respectively. The
comparison of categorical parameters was analyzed by
using Chi-Square test or Fisher’s exact test. Time to res-
cue analgesic administration in the groups was analyzed
by using Kaplan-Meier and the log-rank test (mean
time, median time, 95% CI). A power analysis was per-
formed by statistic program G*Power vr 3-1-2, using the
mean time period from the end of anesthesia to the first
analgesic request. A one way ANOVA analysis, sample
sizes of 21, 23, and 22 were obtained from three groups
whose means were to be compared. The total sample of
66 subjects achieved a 100% power to detect differences
among the means versus the alternative of equal means
using an F test with a 0.05 significance level. The com-
mon standard deviation within a group is assumed to be
8,00. All tests are two-sided. A p < 0.05 value was con-
sidered to be statistically significant. The statistical ana-
lysis was performed with the SPSS, version13.00 (SPSS
Inc, Chicago, IL).
Results
Of the 66 patients studied in the analysis, one more
patient in the control group was also excluded because
of failure to localize the sciatic nerve with stimulator
guidance (Figure 1). The groups were comparable with
respect to demographic data (age in years, weight, and
sex), the type of operation, and the total anesthesia time
(Table 1). A remarkable similarity of attempts to the
ease of sciatic nerve localization was observed (p =
0.503).
Intraoperatively in clonidine, and clonidine plus ropi-
vacaine groups the hemodynamic parameters SAP, DAP,
HR were maintained to the lower normal values so that
no patient needed nalbuphine, under 0.6 MAC sevoflur-
ane anesthesia. On the contrary, in the control group,
increased sevoflurane concentration (MAC up to1.3),
and nalbuphine infusion (0.09 mg/kg/h, mean value:
5.097 ± 3.33), were required in the patients, to maintain
the parameters to the lower normal values until the end
of the operation.
Postoperatively, the Kaplan- Meier analysis (Figure 2),
shows the time from the end of anesthesia to the first
analgesic request which differed significantly between
the three groups (overall p < 0.0005). Particularly, the
patients in the clonidine plus ropivacaine group had a
significantly longer time to first analgesic request com-
pared to clonidine group (Figure 2), [mean time: 21.5
hours, SEM: 1.26, SD:5.90, 95% CI:19.0-23.9 versus 11.6
hours, SEM:1.74 SD: 8.33, 95% CI: 8.2-15.1, median
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hours, range:6-24, 95% CI: 5.6-6.4], (p = 0.001). On the
contrary to the control group that all patients required
rescue nalbuphine in the recovery room (time:0), the
patients in the clonidine group had a longer mean time
to first rescue nalbuphine (p < 0.0005) (Figure 2).
The mean pain CAS score also differed significantly
between the three groups (overall p < 0.0005), (Figure
3 ) .I nt h er e c o v e r yr o o m( t i m e0 )t h em e a np a i nC A S
score was similar in normal values concerning the cloni-
dine and clonidine plus ropivacaine groups and signifi-
cantly lower than in the control group (p < 0.0005)
(Figure 3). No patient in the clonidine and clonidine
plus ropivacaine groups complained for tourniquet pain,
indicating the success of the femoral block as a supple-
ment of perioperative analgesia. On the contrary, all
patients in the control group complained for tourniquet
pain.
In the ward the mean pain CAS score in clonidine and
clonidine plus ropivacaine groups was lower than in the
control group (p < 0.0005), while at 4 and 6 hours post-
operatively the mean pain CAS score in clonidine plus
ropivacaine group was lower than in the clonidine
group (p < 0.05), (Figure 3).
According to the protocol, a rescue dose of 0.2 mg/kg
nalbuphine was given as follows: In the clonidine plus
ropivacaine group four patients required one rescue







Patients between January 2009-May 
2010 for SLPB and femoral block 
assessed for eligibility (n=77)  
Excluded (n=11) 
  Children with neuromuscular 
or neurologic disease or 
problems in communication 
  Children’s parents refusal 
Control group (n=21) 
Clonidine group (n=23)  Clonidine plus ropivacaine 
0.2% (n=22) 
Don’t meet criteria (n=1) 
failure SLPS block 
Meet criteria (n=20) 
     Excluded 
Analyzed (n=22)  Analyzed (n=23)  Analyzed (n=20) 
    Randomized (n=66)                  
Figure 1 Flow diagram of the study.











Age (years). 9 (± 2) 10 (± 2) 10 (± 2) 0.254
Sex (M|F) 7/13 13|10 10|12 0.466












Mild Clubfoot 12 13 12 0.5
Achilles’ lengthening 8 10 10 0.126
Data are presented as mean ± SD
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control group 15 patients required 3 rescue doses of
nalbuphine and 5 required 2 doses. However, nine of
them required a rescue dose of 0.3 mg/kg, because of a
pain CAS score more than 45 mm at 6 hours
postoperatively.
The sensory block in the distribution of all the area of
the sciatic nerve or/the CPN, and in the area of the
femoral nerve, in the clonidine plus ropivacaine group
lasted 16.45 ± 5.81 hours, and 8.6 ± 2.6 hours respec-
tively. No patient in the clonidine group presented sen-
sory block.
Furthermore, most children of clonidine plus ropiva-
caine, and clonidine groups, eliciting plantar flexion or
strong inversion of the foot presented better postopera-
tive analgesia and required fewer rescue doses of nalbu-
phine compared to children eliciting dorsiflexion of the
foot (Chi-Square = 18.66, p = 0.003).
None of the patients in clonidine, and clonidine plus
ropivacaine groups presented motor block.
In the recovery, all the patients of clonidine and cloni-
dine plus ropivacaine groups were calm versus 9
patients of the control group (p < 0.005). In the ward
during the 24 hours postoperative observation period,
10 of the 20 patients of control group presented PONV
once, but none in the clonidine/clonidine plus ropiva-
caine groups (p < 0.005).
In clonidine plus ropivacaine group 6 of the 22
patients were sedated (level 1) lasting one hour versus
sedation level 0 in all patients of control and clondine
groups. In this study, none of the patients presented
side effects due to SLPB.
During the second postoperative day, the parents of
children, of control, clonidine and clonidine plus ropiva-
caine groups expressed a satisfaction mean score of 7.50
± 0.70, 9.74 ± 0.45, 9.73 ± 0.70 respectively (p < 0.0005)
about the perioperative management of their children.
Discussion
Our results demonstrate that intra- and postoperative
analgesia using combined SLPB plus femoral block
either with clonidine alone or clonidine plus ropivacaine
for mild to moderate painful foot and ankle surgery in
children is effective and safe.
In our study, clonidine administered alone in the
SLPB seems promising, maintaining intraoperatively the
hemodynamic parameters SAP, DAP, HR to the lower
normal values so that no patient needed nalbuphine
under 0.6 MAC sevoflurane anesthesia, and postopera-
tively without analgesic request for a median time of 6
Figure 2 Kaplan-Meier analysis. Estimation of survival analysis of the time from the end of anesthesia to the first analgesic request in the
Control, Clonidine and Clonidine plus 0.2% Ropivacaine groups.
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enhances ropivacaine’s analgesic effect for the first post-
operative day in the majority of children (p = 0.001). On
the contrary, the patients of the control group required
high doses of nalbuphine given as continuous intrave-
nous infusion intraoperatively, and in multiple bolus
doses postoperatively. Moreover, assessing the cardio-
vascular parameters this group required high concentra-
tion of sevoflurane resulting in a high incidence of
PONV [21,22].
Our results also show that in most children, eliciting
plantar flexion or strong inversion of the foot, had bet-
ter quality of analgesia requiring fewer rescue doses of
nalbuphine. This is ought to the better spread of local
anesthetic solution, when the injecting needle tip pre-
sumably lies between the common peroneal nerve
laterally and the tibial nerve medially (plantar flexion of
the foot), or very close to the trunk of the sciatic nerve
before its division (strong inversion of the foot).
The peripheral analgesic effect of clonidine appears
clear in a few adults trials, via a local mechanism (drug
interaction, action on peripheral a2-receptors, or both)
after peripheral blocks or intra-articularly. This is sup-
ported by the lower clonidine plasma concentrations in
block treatment group compared to the systemic treat-
ment group [2,3,7,23,24]. Particularly, in a study cloni-
dine without local anesthetic given through an
interscalene catheter provided better analgesia compared
with the systemic administration of the same dose [7].
In children, the evidence concerning perineural adminis-
tration of clonidine is so far inconclusive, as different
types and volume of local anesthetics agents have been
 
  0 hr  2 hr  4 hr  6 hr  8 hr  10 hr  18 hr  24hr 
CTL  39.7±2.3  20.8±4.0  28.6±2.2  47.7±4.25  18.6±6.3  23.9±7.6  33.2±12.8  11.0±4.3 
CLON  9.1±6.1  12.6±6.0  19.4±8.8  24.5±11.8  7.22±9.1  5.3±94.7  7.1±4.3  7.5±4.1 
CLON.ROP  8.8±7.2  8.9±5.5  11.1±6.5  12.9±8.5  12.7±7.6  15.4±9.6  15.5±10.2  13.2±11.5 
Overall  
F-value  200,67  27,83  37,11  79,80  11,22  32,67  40,79  3,48 
F 0.05, 2, 64 
Values are mean±SD   
p<0,0005  CTL vs CLON, and CLON.ROP respectively at each time point, except 24hr 
p<0,05    CLON vs CLON.ROP  4, 6 h postoperatively.       
Figure 3 CAS pain between groups. The mean pain CAS score (mm) at rest in the Control, Clonidine, and Clonidine plus 0.2% Ropivacaine
groups at 0, 2, 4, 6, 8, 10, 18, 24 h time points after surgery.
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of regional anesthesia is largely affected by the opera-
tor’s technique and accuracy and severity of operation.
Therefore, we decided in this study to investigate clo-
nidine effect as an adjuvant in ropivacaine or alone
administered in the SLPB in a definite scheme, assuming
that intravenous or intramuscular clonidine may be
associated with more side effects (e.g. hypotension, bra-
dycardia) in children. Nevertheless, in this study a sys-
temic effect of clonidine cannot be excluded, indicating
the calmness without postoperative delirium, as well as
without incidence of shivering and PONV, that could be
ought to the use of sevoflurane, in the patients of both
SLPB. These effects could make clonidine a useful oral
premedication medicine in children [25,26].
In our study the lack of sensory and motor block by
clonidine alone may be attributed to the small predeter-
mined doses [6]. Furthermore, it was not found motor
block in clonidine plus ropivacaine group, confirming
previous studies that demonstrate that 0.2% ropivacaine
provides preservation of motor function [27].
The analgesic action of clonidine in the SLPB may be
explained by the progressive reduction of the myelin
layers from the proximal to the distal nerve fibers as in
the sciatic nerve at the popliteal fossa, rendering the clo-
nidine more accessible. On the contrary, the denser
myelin layers proximal fibers, like the brachial plexus,
render clonidine added to 0.2% ropivacaine less accessi-
ble, with confined analgesic action but 0.2% ropivacaine
alone has also even less analgesic effect [12]. A direct
local anesthetic action of clonidine on neural
transmission is the most probable suggested mechanism,
mediated by primary afferent terminal a2- adrenergic
nociceptors of subtypes C (the more numerous at the
primary afferent terminals than on the axons), and 2A
(peripheral and central sites), resulting in a decrease in
cAMP in the primary afferents and inhibition of PGE2
hyperalgesia [23,28-31].
Consequently, the effect of clonidine, administered
alone at the distal nerve blocks or added to ropivacaine,
seems promising in the less painful foot surgeries like
Achilles lengthening and mild clubfoot of our patients.
However, the effect of clonidine in severe painful foot,
ankle and knee surgery remains questionable [10] or
potentially with confined analgesia [11].
It has been suggested that an effective block by a large
dose of long acting local anaesthetic may reduce the
incidence of tourniquet pain by blocking C and Aδ
fibres [32]. However, in our study the limited duration
of the foot surgery and the added clonidine in the
femoral block demonstrated the absence of incidence of
tourniquet pain [32] in clonidine group and clonidine
plus 0.2% ropivacaine group, while all the patients in the
control group complained of mild tourniquet pain with
CAS score 30 mm- 35 mm in the area of its application.
The tourniquet pain was also differentiated by the more
intense surgical pain with CAS score > 30-55 mm.
In this study, one could be claimed to the role of 0.2%
ropivacaine alone or systemic clonidine. However, adult
studies have shown a more clearly peripheral effect of
clonidine versus its systemic effect [2,3,7,24] indicating a
challenge to us for further investigation of clonidine
Figure 4 Rescue doses of Nalbuphine. Rescue doses of Nalbuphine in the Control, Clonidine and Clonidine plus 0.2% Ropivacaine groups at 0
up to 24 h after surgery.
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results demonstrated the superior analgesic effect of clo-
nidine administered as adjuvant for 0.2% ropivacaine in
SLPB in comparison to previous paediatric studies using
0.2% ropivacaine alone in the popliteal fossa block for
similar painful foot procedures [33] or in the axillary
brachial plexus block [12].
Conclusions
In conclusion, clonidine appears promising more as an
adjuvant in 0.2% ropivacaine and less than alone in the
SLPB plus femoral block with regard to mild, moderate
intraoperative and postoperative pain management,
along with the absence of incidence of PONV, and the
high parental satisfaction, in children undergoing foot
surgery. Considering the lack of similar studies in chil-
dren using this technique in this single shot scheme,
further investigation is needed to elucidate the definite
role of clonidine, and the utility of SLPB for effective
analgesia and patient outcome after foot, ankle and knee
surgery.
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